Equity
€510,840 ▲ 1.9%
DIABTHIC has made a profit without a break since 2013.
DIABTHIC
Lifetime
20 annual accounts with figures on one time axis, 22 filings since 2004peak €209,911 (2024)
€155,812▼ 25.8%
lowest -€13,295 (2006)
€9,722▼ 81.8%
peak €510,840 (2025)
€510,840▲ 1.9%
€392,129▼ 3.5%
peak 0.3 FTE (2009)
-not published
Board1 name since 2021
1 director
Documentsfilings and deeds
24-07-20267 days before the deadline
2025micro format
Gross margin from €209,911 to €155,812Result from €53,541 to €9,722Cash from €54,875 to €141,683
Key points
from the 2025 annual accountsFilings
22 annual accounts since 2004
Six of the last ten came late. The 2021 accounts came latest: 72 days after the end of the period.
Position in the sector
€9,722
Lower net result than 83% of companies in human health. Sector median €59,563 · 21,309 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 14,768 companies had the same profile as DIABTHIC has now. Each dot stands for 37 companies, two years later.
96.1%
were still trading
3.5%
stopped another way
0.2%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 14,768 companies, not a prediction for DIABTHIC. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Purpose change
“À titre accessoire,la société pourra également avoir pour objet la constitution,la gestion et la valorisation…” (deed in French) · General meeting of 26-05-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0479905322
Registered office moved from Woluwe-Saint-Lambert to Nivelles
New registered office: Rue de l’Athénée 17 boîte 502, 1400 Nivelles · Previous registered office: Avenue Marcel Thiry 97 boîte 3, 1200 Woluwe-Saint-Lambert · Reappointment: (sole director) · General meeting of 04-01-2024 · Gazette deed
Registered office moved from Beauvechain to Brussels
New registered office: Avenue Marcel Thiry 97 bte 03 à 1200 Bruxelles · Previous registered office: Rue Saint-Corneille, H.-M. 63 à 1320 Beauvechain · General meeting of 30-06-2016 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DIABTHIC Nivelles | €902,969 | €155,812 | 56.6% | - |
| DOKTER BART KESTENS Tienen | €823,538 | €150,201 | 93.6% | - |
| CEO MEDICAL Auderghem | €981,120 | €154,885 | 30.3% | - |
| Dokter Koen hendrickx gastro-enteroloog Sint-Martens-Latem | €965,365 | €164,467 | 17.0% | - |
| ORLAM Woluwe-Saint-Pierre | €939,107 | €162,172 | 93.7% | - |
| DOCTEUR MICHEL JAKUBIAK Gerpinnes | €994,707 | €149,178 | 60.7% | - |
| OPHTADERM Montigny-le-Tilleul | €833,770 | €150,736 | 44.4% | - |
These companies have the same main activity as DIABTHIC: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €824,000 and €995,000, founded between 2000 and 2005.
Official details
Source: KBO- Status
- Active since 26-03-2003Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Financial year end
- 31 December
- Peppol
- Reachable since 08-10-2025
Annual accounts 2025
- ≈ €290,000estimated
- €902,969▼ 0.5%
- Filing
- Filed on 24-07-2026, 7 days before the end of the filing period
Insights on DIABTHIC
DIABTHIC files the micro format. That format states no turnover. The gross margin rose from €47,170 in 2006 to €155,812 in 2025.
The balance sheet grew most from 2016 to 2018 through fixed assets, financed with long-term debt.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DIABTHIC
- What is the company number of DIABTHIC?
- The company number of DIABTHIC is 0479.905.322. The VAT number is the same number with BE in front: BE 0479.905.322.
- Where is DIABTHIC based?
- The registered office is at Rue de l'Athénée 17, 1400 Nivelles.Company details
- What does DIABTHIC do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DIABTHIC?
- DIABTHIC is a private limited company (BV).
- When was DIABTHIC founded?
- DIABTHIC was founded on 26-03-2003.
- Is DIABTHIC still active?
- Yes, DIABTHIC is an active enterprise in the KBO register.
- What is the turnover of DIABTHIC?
- The turnover in financial year 2025 is ≈ €290,000. This figure is estimated from the gross margin of €155,812 and 40 comparable companies (NACE 86220). It probably lies between €250,000 and €390,000.Financials
- Is DIABTHIC profitable?
- In financial year 2025, DIABTHIC made a profit of €9,722.
- Where can I find the annual accounts of DIABTHIC?
- DIABTHIC filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DIABTHIC due?
- DIABTHIC must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.